DERM vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

DERM

39.8
AI Score
VS
CRON Wins

CRON

63.0
AI Score

Investment Advisor Scores

DERM

40score
Recommendation
SELL

CRON

63score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DERM CRON Winner
Revenue 34.47M 98.22M CRON
Net Income -2.54M 45.84M CRON
Net Margin -7.4% 46.7% CRON
Operating Income -1.04M 5.57M CRON
ROE -7.9% 4.3% CRON
ROA -2.6% 3.9% CRON
Total Assets 98.36M 1.18B CRON
Cash 25.64M 467.02M CRON
Current Ratio 1.59 16.18 CRON

Relative Price Performance (Last 90 Days)

DERM 1M: -24.8% · 3M: -21.0% CRON 1M: +1.3% · 3M: +22.6%

Current Technical Phase

DERM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.1%), weak momentum, RSI 31

RSI (14): 30.9 · Price: $4.89

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.1% over 20 days), RSI 65

RSI (14): 65.4 · Price: $3.45

Fundamentals Snapshot

Metric DERM CRON
Market Cap — —
Forward P/E 7.1 13.6
Trailing P/E — 17.3
Revenue (TTM) — —
Revenue Growth 0.2% 0.6%
Gross Margin 0.7% 0.4%
Operating Margin 0.0% 0.2%
EPS -0.22 0.19
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.